Advertisement
SAN JOSE, Calif., June 17, 2020 /PRNewswire-PRWeb/ -- LifePlus, a next generation medical device company, previewed the breakthrough technology behind its flagship smartwatch that provides a continuous real time and truly non-invasive way to measure and monitor five different vitals including blood glucose. LifePlus CEO, Dr. Alodeep Sanyal, presented this preview in the DIABESTSMINE D-DATA EXCHANGE forum, held on June 12th in conjunction with the American Diabetes Association 80th Annual Scientific Sessions.
Dr. Sanyal stated, "Research shows almost everyone who develops Type 2 diabetes, develops prediabetes first. But not everyone who has prediabetes ends up with diabetes. Prediabetes can be reversed if acted upon early and carefully. Creating a wearable specifically designed to reverse the effects of prediabetes has been our mission for over 5 years."
"Our goal is to provide the world's first, truly non-invasive wearable for continuous tracking of blood glucose, eliminating painful finger sticks." Dr. Sanyal adds, "Our wearable will continuously & non-invasively track blood glucose, blood pressure, heart rate, heart rate variability, oxygen saturation and respiration rate providing a comprehensive, '360º' view of your metabolic and cardiovascular health."
After the presentation Dr. Sanyal engaged in a lively Q&A session with attendees answering questions about LifePlus' initial focus on prediabetes, availability of their open API to integrate with other diabetes management solutions, and how people can participate in early trials.
The first version of the LifeLeaf product will be available this fall through Hovid Pharmaceuticals in Malaysia and other South-East Asian markets. US availability will follow FDA approval which is currently in progress.
About LifePlus LifePlus is a Silicon Valley, California based technology company that develops and manufactures next generation connected and smart medical devices addressing long-standing medical challenges. Their flagship product, LifeLeaf, is a smartwatch that uses spectroscopic signals to measure five different vitals including blood glucose, blood pressure, heart rate, respiration rate and blood oxygen saturation. A continuous, real time and non-invasive measurement of these vitals provide functional and practical solutions for people suffering from chronic conditions, such as diabetes and hypertension. Learn more about LifePlus at http://www.lifeplus.ai.
Trademarks LifeLeaf is a registered trademark of LifePlus, Inc.
Keywords Diabetes, Blood Glucose, CGM, Glucometer, smartwatch
SOURCE LifePlus, Inc.
Advertisement
Dr. Sanyal stated, "Research shows almost everyone who develops Type 2 diabetes, develops prediabetes first. But not everyone who has prediabetes ends up with diabetes. Prediabetes can be reversed if acted upon early and carefully. Creating a wearable specifically designed to reverse the effects of prediabetes has been our mission for over 5 years."
"Our goal is to provide the world's first, truly non-invasive wearable for continuous tracking of blood glucose, eliminating painful finger sticks." Dr. Sanyal adds, "Our wearable will continuously & non-invasively track blood glucose, blood pressure, heart rate, heart rate variability, oxygen saturation and respiration rate providing a comprehensive, '360º' view of your metabolic and cardiovascular health."
After the presentation Dr. Sanyal engaged in a lively Q&A session with attendees answering questions about LifePlus' initial focus on prediabetes, availability of their open API to integrate with other diabetes management solutions, and how people can participate in early trials.
The first version of the LifeLeaf product will be available this fall through Hovid Pharmaceuticals in Malaysia and other South-East Asian markets. US availability will follow FDA approval which is currently in progress.
About LifePlus LifePlus is a Silicon Valley, California based technology company that develops and manufactures next generation connected and smart medical devices addressing long-standing medical challenges. Their flagship product, LifeLeaf, is a smartwatch that uses spectroscopic signals to measure five different vitals including blood glucose, blood pressure, heart rate, respiration rate and blood oxygen saturation. A continuous, real time and non-invasive measurement of these vitals provide functional and practical solutions for people suffering from chronic conditions, such as diabetes and hypertension. Learn more about LifePlus at http://www.lifeplus.ai.
Trademarks LifeLeaf is a registered trademark of LifePlus, Inc.
Keywords Diabetes, Blood Glucose, CGM, Glucometer, smartwatch
SOURCE LifePlus, Inc.
